Cannaisseur Group Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Cannaisseur Group Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $700 | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $53.1K | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $88.1K | Apr 15, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($910) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($3.6K) | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $26.2K | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $45.3K | Apr 15, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.77M) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($1.27M) | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | ($128.0K) | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | ($80.1K) | Apr 15, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.72M) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($1.27M) | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | ($189.9K) | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | ($91.9K) | Apr 15, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($127.5K) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($110.6K) | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | ($126.1K) | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | ($23.9K) | Apr 15, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $140 | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $1.9K | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $43.7K | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $59.3K | Apr 15, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $235.4K | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $305.6K | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $136.7K | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $81.7K | Apr 15, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.49M) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($1.71M) | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | ($445.5K) | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | ($317.5K) | Apr 15, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22 | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $563 | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $38.4K | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $18.5K | Apr 15, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $72.2K | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | $27.3K | Apr 15, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 15, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 15, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 60.46M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | 44.34M | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | 42.55M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | 37.20M | Apr 15, 2024 |